[go: up one dir, main page]

AU3011497A - Novel human growth factors - Google Patents

Novel human growth factors

Info

Publication number
AU3011497A
AU3011497A AU30114/97A AU3011497A AU3011497A AU 3011497 A AU3011497 A AU 3011497A AU 30114/97 A AU30114/97 A AU 30114/97A AU 3011497 A AU3011497 A AU 3011497A AU 3011497 A AU3011497 A AU 3011497A
Authority
AU
Australia
Prior art keywords
growth factors
human growth
novel human
novel
factors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30114/97A
Inventor
Patrick J. Dillon
Reinhard Ebner
Gregory A. Endress
Guo-Liang Yu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU3011497A publication Critical patent/AU3011497A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU30114/97A 1996-08-23 1997-09-11 Novel human growth factors Abandoned AU3011497A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
WOUS9613766 1996-08-23
US9613766 1996-08-23
PCT/US1997/014139 WO1998007749A1 (en) 1996-08-23 1997-08-22 Novel human growth factors

Publications (1)

Publication Number Publication Date
AU3011497A true AU3011497A (en) 1998-03-06

Family

ID=22255670

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30114/97A Abandoned AU3011497A (en) 1996-08-23 1997-09-11 Novel human growth factors

Country Status (4)

Country Link
EP (1) EP0929575A4 (en)
JP (1) JP2002508652A (en)
AU (1) AU3011497A (en)
WO (1) WO1998007749A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999002559A1 (en) * 1997-07-07 1999-01-21 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
AU2005218046B2 (en) * 2000-02-25 2008-07-03 Ucb Pharma S.A. Use of breast cancer associated membrane proteins (BCMP) for treatment, prophylaxis and diagnosis of breast cancer
GB0004576D0 (en) * 2000-02-25 2000-04-19 Oxford Glycosciences Uk Ltd Proteins
DE60126248T2 (en) * 2000-02-25 2007-07-05 Ucb S.A. USE OF BREAST CANCER MEMBRANE PROTEINS FOR TREATMENT, PROPHYLAXIS AND DIAGNOSIS OF BREAST CANCER
US20040141974A1 (en) * 2000-02-25 2004-07-22 Boyd Robert Simon Diagnostic and therapeutic methods
US20020015956A1 (en) * 2000-04-28 2002-02-07 James Lillie Compositions and methods for the identification, assessment, prevention, and therapy of human cancers
EP1666492A1 (en) * 2000-06-02 2006-06-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
RU2166957C1 (en) * 2000-10-09 2001-05-20 Санкт-Петербургская Общественная Организация "Санкт-Петербургский Институт Биорегуляции И Геронтологии Сзо Рамн" Tetrapeptide stimulating functional activity of hepatocytes, pharmacological agent based on thereof and method of its use
GB0222787D0 (en) * 2002-10-02 2002-11-06 Univ Liverpool Metastasis inducing compounds
JP2004298112A (en) * 2003-03-31 2004-10-28 Japan Science & Technology Agency Human solid tumor antigen peptide, polynucleotide encoding the same, and use thereof
GB0307918D0 (en) 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
ES2299281B1 (en) * 2003-10-22 2009-04-16 Progenika Biopharma, S.A. METHODS FOR IN VITRO AND FORECAST IN VITRO DIAGNOSIS OF THE CANCER OF PANCREAS, AND FOR THE DEVELOPMENT OF PHARMACOS AGAINST CANCER OF PANCREAS.
JP2007520217A (en) * 2004-01-27 2007-07-26 コンピュゲン ユーエスエイ，インク． Novel nucleotide and amino acid sequences, and assays and methods of use for breast cancer diagnosis using the same
WO2008026009A1 (en) * 2006-08-29 2008-03-06 Oxford Genome Sciences (Uk) Ltd Protein
WO2008104803A2 (en) * 2007-02-26 2008-09-04 Oxford Genome Sciences (Uk) Limited Proteins
EP3593802A3 (en) 2010-05-26 2020-03-25 Satiogen Pharmaceuticals, Inc. Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
BR112014010223B8 (en) 2011-10-28 2021-02-23 Lumena Pharmaceuticals Llc use of a composition comprising bile acid recycling inhibitors and pediatric dosage form
AU2012328453B2 (en) 2011-10-28 2017-05-04 Shire Human Genetic Therapies, Inc. Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
AU2014229050A1 (en) 2013-03-15 2015-10-22 Lumena Pharmaceuticals Llc Bile acid recycling inhibitors for treatment of Barrett's esophagus and gastroesophageal reflux disease
BR112015023646A2 (en) 2013-03-15 2017-07-18 Lumena Pharmaceuticals Inc Recycling bile acid inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease
BR112021015799A2 (en) 2019-02-12 2022-01-18 Mirum Pharmaceuticals Inc Methods to enhance growth in pediatric patients with cholestatic liver disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998011217A2 (en) * 1996-09-13 1998-03-19 Sagami Chemical Research Center HUMAN PROTEINS HAVING SECRETORY SIGNAL SEQUENCES AND DNAs ENCODING THESE PROTEINS
AU6762298A (en) * 1997-03-19 1998-10-12 Zymogenetics Inc. Secreted polypeptides with homology to xenopus cement gland proteins
PT1000146E (en) * 1997-08-01 2006-10-31 Serono Genetics Inst Sa ESTS 5 'FOR SECRET PROTEINS WITHOUT TECS SPECIFICITY

Also Published As

Publication number Publication date
WO1998007749A1 (en) 1998-02-26
JP2002508652A (en) 2002-03-19
EP0929575A4 (en) 2004-09-08
EP0929575A1 (en) 1999-07-21

Similar Documents

Publication Publication Date Title
EP0784967A3 (en) Spine implant
AU4886297A (en) Artificial cornea
EP0797962A3 (en) Areal implant
AU2226297A (en) Surgical model
AU2207797A (en) Human bikunin
AU1868595A (en) Human growth hormone
AU5407598A (en) Bone implant
AU5721798A (en) Human mage-like protein
EP0871705A4 (en) Human ccn-like growth factor
AU3728197A (en) Human telomerase
AU3198297A (en) Biocompatible glue
AU3011497A (en) Novel human growth factors
AU1566897A (en) Pruning implement
AU3921993A (en) Novel antler-derived bone growth factors
AU4480697A (en) Human nm23-like protein
AU5390396A (en) Extracellular/epidermal growth factor hcaba58x
AU2375495A (en) Prosthesis
AU2653095A (en) Fibroblast growth factor-14
AU3207195A (en) Growth stimulating factors
AU5471098A (en) Bone stimulating factor
AU1401495A (en) Human vascular ibp-like growth factor
AU4744997A (en) Novel human phospholemman-like protein
AU5723996A (en) Human rad
AU5487598A (en) Breast implant
AU2766495A (en) Human criptin growth factor